The stock's 50 day moving average is 1.55 and its 200 day moving average is 1.32.
Celsion Corporation (NASDAQ:CLSN) last traded at $5.33 with a low of $1.95 and high of $5.85. This company shares are 48.51% off its target price of $9 and the current market capitalization stands at $52.12M. Based on a recent trade, the shares are -65.09% away from the 52-week high and 388.71% from the 52-week low.
Looking into last 5 trades, the stock observed a return of nearly 288.46%. The shares price has positioned 150.41% up over the past quarter while it has directed 49.26% toward a rising position throughout past six months. Zacks Investment Research cut Celsion Corporation from a "buy" rating to a "hold" rating in a research note on Monday, June 26th. Renaissance Technologies Llc owns $335 thousand in Celsion Corporation, which represents roughly 0.64% of the company's market cap and approximately 33.5% of the institutional ownership.
Celsion Corporation (CLSN) reported that final clinical and translational research data from its OVATION Study, a Phase Ib dose escalating clinical trial combining GEN-1, the Company's DNA-based immunotherapy, with the standard of care for the treatment of newly-diagnosed patients with advanced Stage III/IV ovarian cancer who will undergo neoadjuvant chemotherapy followed by interval debulking surgery. RSI levels 70 and above are considered overbought with RSI's under 30 indicating oversold. The stock's short float is around of 10.45% and short ratio is 0.45. That puts total institutional holdings at 624,003 shares, according to SEC filings. The overall volume in the last trading session was 74.44 Million shares. Including today's unusual volume, Celsion Corporation's stock is performing at 42.43% on the year. In the past 3-month period alone, shares of CLSN have appreciated - or. Institutional owners hold 7.50% stake in the company, while insiders ownership held at 0.10%. The shares price has directed -63.93% toward a lower level throughout a year ago and swapped 355.64% toward a strong spot during past one month. For every buyer, there needs to be someone who sold them the shares they bought, just as there must be a buyer in order for a seller to get rid of his or her shares. Of those insider trades, 13,000 shares of Celsion Corporation were purchased and 0 shares were sold.
In the transaction dated November 14, 2016, the great number of shares acquired came courtesy the Director; Martinez Alberto R Jr added a total of 714 shares at an average price of $12.04, amounting to approximately $8,597. They now have a Dollars 10 price target on the stock.